Evaluation of tissue trauma and healing on the basis of tumour necrosis factor-alpha, interleukin-6, and C-reactive protein in peripheral blood during and after pyometra in bitches

• Autorzy: Toydemir Karabulut T.S.F. , Sonmez K.
• Języki publikacji: EN

Abstrakty

EN

In this study, inflammation in the blood of bitches with pyometra (PG) was compared before and 15 days after ovariohysterectomy (OVH). The results were compared with those for control dioestrus bitches (CG) to reveal the evidence of inflammation in blood after a routine surgery. Inflammation was tracked by tumour necrosis factor-alpha (TNF-α), interleukine-6 (IL-6) and C-reactive protein (CRP), using immunocytochemistry (ICC) and immunofluorescence capture of blood cells in cell blocks. ICC is performed mainly during routine cytological examinations, whereas the use of cell blocks in blood examination is uncommon. Insofar as we know, this is the first study using cell block techniques on canine blood samples. Three commercially available antibodies against TNF-α, IL-6 and CRP, forming two panels, were evaluated. A standard streptoavidin-biotin complex technique was used for ICC. TNF-α and IL-6 labelling was scored for colour and intensity, and CRP for immunofluorescence capture. TNF-α and IL-6 colour and intensity scores differed significantly between the PG and CG groups, and were higher in PG before OVH (P < 0.01, P < 0.01, P < 0.001, P < 0.01, respectively). IL-6 intensity was significantly greater in PG 15 days after OVH (P < 0.05). CRP capture in PG was strong before OVH and high in both groups 15 days later. Low-dose anti-inflammatory agents or an anti-cytokine therapy may be useful in pyometra treatment in the future because these treatments may offer protection from systemic inflammatory response syndrome before and after OVH.

Słowa kluczowe

EN

dog; female; bitch; inflammation; systemic inflammatory response syndrome; tissue trauma; healing; tumour necrosis factor-alpha; interleukin 6; C-reactive protein; blood; peripheral blood; pyometra; therapy

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2018
• Tom: 74
• Numer: 10
• Opis fizyczny: p.658-664,fig.,ref.

Twórcy

autor

Toydemir Karabulut T.S.F.

• Department of Gynaecology and Obstetrics, Faculty of Veterinary Medicine, Istanbul University, Avcılar Campus, Istanbul, 34320, Turkey

autor

Sonmez K.

• Department of Pathology, Faculty of Veterinary Medicine, Istanbul University, Avcılar Campus, Istanbul, 34320, Turkey

Bibliografia

• Bar-Or D., Carrick M. M., Mains C. W., Rael L. T., Slone D., Brody E. N.: Sepsis, oxidative stress, and hypoxia: Are there clues to better treatment? Redox Report 2015, 20, 193-197, doi: 10.1179/ 1351000215Y.0000000005.
• Bilous M., Dowsett M., Hanna W., Isola J., Lebeau A., Moreno A., Penault-Llorca F., Rüschoff J., Tomasic G., Vijver M. van de: Current perspectives on HER2 testing: A review of national testing guidelines. Modern Pathology 2003, 16, 173-182, doi: 10.1097/ 01.MP.0000052102.90815.82.
• Birks E. J., Owen V. J., Burton P. B. J., Bishop A. E., Banner N. R., Khaghani A., Polak J. M., Yacoub M. H.: Tumor Necrosis Factor-α Is Expressed in Donor Heart and Predicts Right Ventricular Failure After Human Heart Transplantation. Circulation 2000, 102, 326-331, doi: 10.1161/01.CIR.102.3.326.
• Cavaillon J.-M., Annane D.: Compartmentalization of the inflammatory response in sepsis and SIRS. J. Endotoxin Res. 2006, 12, doi: 10.1179/096805106X102246.
• Ceron J. J., Eckersall P. D., Silvia Martinez-Subiela S.: Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet. Clin. Pathol. 2005, 34, 85-99.
• Drutskaya M. S., Efimov G. A., Astrakhantseva I. V., Kruglov A. A., Nedospasov S. A.: Making anti-cytokine therapy more selective: Studies in mice. Cytokine 2018, 101, 33-38.
• Fransson B. A., Lagerstedt A.-S., Bergstrom A., Hagman R., Park J. S., Chew B. P., Evans M. A., Ragle C. A.: C-reactive protein, tumor necrosis factor a, and interleukin-6 in dogs with pyometra and SIRS. J. Vet. Emerg. Crit. Care 2007, 17, 373-381, doi: 10.1111/j.1476 – 4431.2006.00203.x.
• Hagman R.: Clinical and Molecular Characteristics of Pyometra in Female Dogs. Reprod. Dom. Anim. 2012, 47, 323-325, doi: 10.1111/rda.12031 ISSN 0936-6768.
• Hwang J., Seo Y., Jo Y., Son J., Choi J.: Aptamer-conjugated live human immune cell based biosensors for the accurate detection of C-reactive protein. Sci. Rep. 2016, 6, 34778, doi: 10.1038/srep34778.
• Jain D., Mathur S. R., Iyer V. K.: Cell blocks in cytopathology: a review of preparative methods, utility in diagnosis and role in ancillary studies. Cytopathology 2014, 25, 356-371, doi: 10.1111/cyt.12174.
• Jitpean S., Holst B. S., Höglund O. V., Pettersson A., Strage E. O., Södersten F., Hagman R.: Serum insulin-like growth factor-I, iron, C-reactive protein, and serum amyloid A for prediction of outcome in dogs with pyometra. Theriogenology 2014, 82, 43-48, doi: 10.1016/j.theriogenology.2014.02.014.
• Jitpean S., Ström-Holst B., Emanuelson U., Höglund O. V., Pettersson A., Alneryd-Bull C., Hagman R.: Outcome of pyometra in female dogs and predictors of peritonitis and prolonged postoperative hospitalization in surgically treated cases. BMC Vet. Res. 2014, 10, 6, http://www.biomedcentral.com/1746-6148/10/6.
• Kell D. B., Pretorius E.: To what extent are the terminal stages of sepsis, septic shock, SIRS, and multiple organ dysfunction syndrome actually driven by a prion/amyloid form of fibrin? bioRxiv preprint, 2016, doi: 10.1101/057851.
• Konończuk T., Łukaszuk B., Żendzian-Piotrowska M., Dąbrowski A., Krzyżak M., Ostrowska L., Kurek K.: Plasma Sphingolipids in Acute Pancreatitis. Inter. J. Mol. Sci. 2017, 18, 2606, doi: 10.3390/ijms18122606.
• Kung I. T., Chan S. K., Lo E. S.: Application of the immunoperoxidase technique to cell block preparations from fine needle aspirates. Acta Cytolog. 1990, 34, 297-303.
• Liu S. J., Shi Y., Liu C., Zhang, M., Zuo Z., Zeng C. J., Zhou G. B., Xian H., Song T. Z.: The upregulation of pro-inflammatory cytokines in the rabbit uterus under the lipopolysaccaride-induced reversible immunoresponse state. Anim. Reprod. Sci. 2017, 176, 70-77, doi: 10.1016/j.anireprosci.2016.11.012.
• Liua Z., Fanc Y., Wanga Y., Hana C., Panb Y., Huang H., Yeb Y., Luob L., Yina Z.: Dipyrithione inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in macrophages and protects against endotoxic shock in mice. FEBS Letters 2008, 582, 1643-1650, doi: 10.1016/j.febslet.2008.04.016.
• Maciel G. S., Uscategui R. R., Almeida V. T. de, Oliveira M. E. F., Feliciano M. A. R., Vicente W. R. R.: Quantity of IL-2, IL-4, IL-10, INF-c, TNF-a and KC-Like Cytokines in Serum of Bitches With Pyometra in Different Stages of Oestrous Cycle and Pregnancy. Reprod. Dom. Anim. 2014, 49, 701-704, doi: 10.1111/rda.12360.
• Martin E. M., Messenger K. M., Sheats M. K., Jones S. L.: Misoprostol inhibits lipopolysaccharide-induced pro-inflammatory cytokine production by equine leucocytes. Front. Vet. Sci. 2017, 4, 160, doi: 10.3389/fvets. 2017.00160.
• Mera S. L., Young E. W., Bradfield J. W. B.: Direct immunofluorescence of skin using formalin-fixed paraffin embedded sections. J. Clin. Pathol. 1980, 33, 365-369.
• Nathan N. A., Narayan E., Smith M. M., Horn M. J.: Improved Preparation and Its Efficacy in Diagnostic Cytology. Am. J. Clin. Pathol. 2000, 114, 599-606.
• Otto C. M.: Clinical trials in spontaneous disease in dogs: a new paradigm for investigations of sepsis. J. Vet. Emerg. Crit. Care 2007, 17, 359-367, doi: 10.1111/j.1476-4431.2007.00249.x.
• Plavec T., Celinsek B., Dolinar K., Pecar J., Nemec A., Butinar J.: Haemostasis impairment in bitches with pyometra. Acta Vet. (Beograd) 2006, 56, 529-540, doi: 10.2298/AVB0606529P.
• Radwińska J., Domosławska A., Pomianowski A., Żarczyńska K., Jurczak A.: Implications of blood coagulation and fibrinolytic disorders in severe endometritis-pyometra complex in bitches. Bull Vet. Inst. Pulawy 2012, 56, 293-297, doi: 10.2478/v10213-012-0053-x.
• Schüttler J., Neumann S.: Interleukin-6 as a prognostic marker in dogs in an intensive care unit. Vet. Clin. Pathol. 2015, 44, 223-228, doi: 10.1111/vcp.12255.
• Träger K., Schütz C., Fischer G., Schröder J., Skrabal C., Liebold A., Reinelt H.: Cytokine reduction in the setting of an ARDS-associated inflammatory response with multiple organ failure. Case Rep. Crit. Care 2016, article id 9852073, doi:10.1155/2016/9852073.
• Wang Y.-R., Tsai H.-I., Yu H.-P.: Organ dysfunction following trauma, shock and sepsis: An update. J. Anesth. Periop. Medi. 2015, 2, 36-44.
• Werners A. H.: Treatment of endotoxemia and septicaemia in the equine patient. J. Vet. Pharmacol. Therap. 2016, 40, 1-15, doi: 10.1111/jvp.12329.

Identyfikatory

DOI

10.21521/mw.6122